Zobrazeno 1 - 10
of 50
pro vyhledávání: '"Anda Gershon"'
Autor:
Cristina Julian, Navdeep Pal, Anda Gershon, Marie Evangelista, Hans Purkey, Peter Lambert, Zhen Shi, Qing Zhang
Publikováno v:
BMC Cancer, Vol 23, Iss 1, Pp 1-11 (2023)
Abstract Background KRAS mutations occur frequently in advanced non-small cell lung cancer (aNSCLC); the G12C mutation is the most prevalent. Alterations in STK11 or KEAP1 commonly co-occur with KRAS mutations in aNSCLC. Using real-world data, we ass
Externí odkaz:
https://doaj.org/article/39f659320a5b49a2b4fe8592832b1dcc
Autor:
Cristina Julian, Robson J. M. Machado, Sandhya Girish, Pascal Chanu, Dominik Heinzmann, Chris Harbron, Anda Gershon, Shannon M. Pfeiffer, Wei Zou, Valerie Quarmby, Qing Zhang, Yachi Chen
Publikováno v:
Cancer Reports, Vol 5, Iss 10, Pp n/a-n/a (2022)
Abstract Background and aim The objective of this retrospective, observational, noninterventional cohort study was to investigate prognostic factors of overall survival (OS) in patients with advanced non‐small cell lung cancer (aNSCLC) and to devel
Externí odkaz:
https://doaj.org/article/1d3c8efe775a4a03ae0273cda40bf20a
Autor:
Anda Gershon, Esprit Ma, Tao Xu, Melissa Montez, Kiran Naqvi, Grace Ku, Wendy Wei-Han Cheng, Evelyn M. Flahavan, Vamsi Kota, Daniel R. Greenwald
Publikováno v:
Clinical Lymphoma Myeloma and Leukemia. 23:e222-e231
Autor:
Pankit Vachhani, Evelyn M Flahavan, Tao Xu, Esprit Ma, Melissa Montez, Anda Gershon, Maika Onishi, Huan Jin, Grace Ku, Brannon Flores, Cat N Bui, Jonathan A Abbas, William Donnellan
Publikováno v:
The oncologist. 27(11)
Background Treatment with venetoclax + hypomethylating agents (HMAs) is standard-of-care for newly diagnosed (ND) patients with acute myeloid leukemia (AML) aged ≥75 years, or with comorbidities precluding intensive chemotherapy. We describe real-w
Autor:
Cristina Julian, Robson J. M. Machado, Sandhya Girish, Pascal Chanu, Dominik Heinzmann, Chris Harbron, Anda Gershon, Shannon M. Pfeiffer, Wei Zou, Valerie Quarmby, Qing Zhang, Yachi Chen
Publikováno v:
Cancer Reports. 5
Autor:
Cristina, Julian, Robson J M, Machado, Sandhya, Girish, Pascal, Chanu, Dominik, Heinzmann, Chris, Harbron, Anda, Gershon, Shannon M, Pfeiffer, Wei, Zou, Valerie, Quarmby, Qing, Zhang, Yachi, Chen
Publikováno v:
Cancer reports (Hoboken, N.J.). 5(10)
The objective of this retrospective, observational, noninterventional cohort study was to investigate prognostic factors of overall survival (OS) in patients with advanced non-small cell lung cancer (aNSCLC) and to develop a novel prognostic model.A
Publikováno v:
Journal of Psychiatric Research. 116:14-18
Background Ecological momentary assessment (EMA) is increasingly used to characterize patients’ daily lives, monitor mood, and test efficacy of treatment interventions. However, few studies have examined patient characteristics impacting adherence
Publikováno v:
Psychiatric Annals. 49:196-201
Over the next 5 years, the evolving landscape of digital devices available to clinicians and their patients will transform the ways that psychiatrists will be able to treat a wide range of neuropsychiatric conditions. In this article, we forecast how
Autor:
Shefali Miller, Farnaz Hooshmand, Bernardo Dell'Osso, Anda Gershon, Dong Yeon Park, Saloni Shah, Dennis Do, Terence A. Ketter, Laura D. Yuen, Po W. Wang
Publikováno v:
Journal of Affective Disorders. 246:836-842
Aims Antidepressants are common in bipolar disorder (BD), but controversial due to questionable efficacy/tolerability. We assessed baseline antidepressant use/depression associations in BD. Methods Stanford BD Clinic outpatients, enrolled during 2000
Autor:
Anda Gershon, Laura D. Yuen, Dennis Do, Saloni Shah, Bernardo Dell'Osso, Farnaz Hooshmand, Hyun Ok Kim, Dong Yeon Park, Shefali Miller, Terence A. Ketter, Po W. Wang
Publikováno v:
Journal of Affective Disorders. 234:74-79
Aims Antidepressant use is controversial in bipolar disorder (BD) due to questionable efficacy/psychiatric tolerability. We assessed demographic/clinical characteristics of baseline antidepressant use in BD patients. Methods Prevalence and correlates